Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dutch approval of Remeron SolTab

July 31, 2001

Results of phase II evaluation of NIL-A in Parkinson's disease reported

July 31, 2001

Neotrofin increases hippocampal stem cells in mice

July 31, 2001

AMPA receptor agonists from ADIR effective in rat models of memory

July 30, 2001

Panacea awarded research grant for Parkinson's disease

July 30, 2001

Selective JNK modulators and their use described by ARS

July 27, 2001

Agouron's new rotamase-inhibitory neurotrophic agents

July 27, 2001

OxyContin labeling changes reflect new FDA warnings

July 27, 2001

Prana Biotechnology awarded a START grant for AD drug development

July 27, 2001

Phase II clinical data for secretin presented at Autism Society meeting

July 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...